Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Requisite for stringent control of oxygen therapy in the neonatal period

B. Fauroux, A. Clément
European Respiratory Journal 2007 29: 4-5; DOI: 10.1183/09031936.00132306
B. Fauroux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Clément
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Brief administrations of oxygen are commonly given to term and premature newborns after delivery or before invasive procedures to prevent hypoxaemia. But, to date, no study has validated the usefulness and innocuity of this pre-oxygenation method. Now, in the current issue of the European Respiratory Journal, Lofaso et al. 1 report the deleterious effects of oxygen administration in newborn mice. The main message of their work is that repeated brief administration of 100% oxygen during a critical window, i.e. the first 3 days of life, was associated with a significant decrease in minute ventilation, owing to an increase in absolute total respiratory time and apnoea duration. Most importantly, these adverse effects increased with repeated exposure. The exposure to a lower concentration of oxygen (30%) produced comparable effects on breathing pattern. In both situations, recovery was observed after return to normoxia. Before analysing the clinical implications of this work, it is worth discussing the methodology of the study.

THE VALUE OF ANIMAL MODELS

It is extremely difficult to perform studies in human newborns and infants because of the multitude of ethical issues and the risks associated with unproven therapies in this vulnerable population. In addition, there is an international agreement among paediatricians on the impossibility of performing invasive or potentially dangerous studies in healthy children or children presenting a mild disease 2, 3. As a consequence, well-conducted animal studies are both necessary and relevant to improve care in infants. A requisite is that the animal model should share the same side-effects and the same period of vulnerability of the organ system as the human child. Mice constitute an excellent model for studying the maturation of respiratory control, as their developmental stage at birth roughly matches that of human pre-term neonates born at 25 weeks gestation 4. Ventilatory responses to hypoxia and hypercapnia in rats and mice have a similar developmental pattern to the human premature infant.

Whole-body flow barometric plethysmography, as developed and used by Lofaso et al. 1, represents the most suitable method for studying ventilation in newborn mice, because it is noninvasive and allows the analysis of unrestrained animals 5, 6. Indeed, when studying breathing pattern in newborn mice, the method of measure should be validated. The low birth weight (1.3 g) and tidal volume (3–4 μL·g-1) of newborn mice preclude the use of devices that are acceptable for adult mice or larger animals. Moreover, stress, such as restraint, exerts a major influence on ventilation and should be avoided. In these small newborn rodents, metabolism is closely coupled to ventilatory response, which requires simultaneous measurement of temperature and metabolism.

CLINICAL IMPLICATIONS

The study by Lofaso et al. 1 underlines the deleterious short-term effects of hyperoxia in newborn mice in inducing hypoventilation and apnoea. Most importantly, they observed that repeated exposure, as frequently encountered in the clinical setting, increasingly depressed breathing. Potential long-term side-effects were not analysed. It is well known that suboptimal environments in the womb and during early neonatal life may alter the development and predispose the individual to permanent, lifelong health problems. Nutrient restriction or overfeeding, maternal stress or exposure to toxins, may be associated with the development of hypertension, diabetes, obesity or altered adrenal function in later life. During development, there are critical periods of vulnerability to suboptimal conditions. Newborn rodents share with humans a critical “window” of vulnerability for the lung and brain tissues at birth. As such, respiratory control impairments at early stages of development compromise brain oxygenation and may cause irreversible motor and cognitive disorders and even structural changes in the specific organ. Newborn rats exposed to chronic hyperoxia have blunted ventilatory responses to hypoxia in adulthood, whereas the same exposure after the neonatal period has little or no effect 7. Post-natal hyperoxia impairs the response to hypoxia in adulthood, as well as the ability to make plastic changes in respiratory control induced by sustained hypoxia 8. Dauger et al. 9 have also shown that hyperoxic exposure during the post-natal period of rapid alveolar multiplication in mice may disturb normal alveolar growth and respiratory mechanics in adulthood.

A factor that could not be analysed in the study by Lofaso et al. 1 was individual susceptibility to post-natal hyperoxia. Bedside data show that some pre-term infants may be predisposed to severe breathing instability, suggesting a role for genetic factors 10, 11. Thus, some newborns may be more susceptible to a hyperoxic insult than others. This concept of respiratory control immaturity, or injury by pre- or post-natal factors, is nowadays recognised as one of the mechanisms that lead to sudden infant death syndrome (SIDS). Indeed, SIDS is observed with an increased frequency in pre-term babies and abnormalities of breathing, such as partial arousal deficiency or a deficiency in serotonin, have been documented in SIDS victims 12.

What strategy can we now propose to prevent the deleterious effects of oxygen administration in the neonatal intensive care unit? Certainly, the use of the lowest concentration of oxygen is strongly recommended. However, while use of a lower concentration of oxygen may be associated with reduced side-effects of oxygen on other organs, with regard to breathing pattern, comparable depressing ventilatory effects were observed when the animals were exposed to an oxygen concentration of 30%. Perhaps it is necessary to evaluate another therapy which aims to maintain, not depress ventilation. Noninvasive positive pressure ventilation (NPPV), using a pre-set value of inspiratory pressure, may be worth evaluating as a safer technique to prevent hypoxia. Indeed, a recent prospective study compared noninvasive pressure support ventilation with positive end-expiratory pressure, delivered by means of a face mask, with the classical method using a nonrebreather bag-valve mask driven by 15 L·min−1 oxygen during orotracheal intubation in critically ill adults 13. NPPV was significantly more effective at reducing arterial oxyhaemoglobin desaturation than the usual method. Premature and term newborns are not adults, but a therapeutic strategy that increases tidal volume and minute ventilation may be associated with less ventilatory depression and potential long-term side-effects than hyperoxia. Of course, such a treatment should be validated and efficacious without additional oxygen.

The lesson of the work of Lofaso et al. 1 is that therapeutic strategies commonly used in clinical practice should be questioned and, most importantly, rigorously evaluated.

    • © ERS Journals Ltd

    References

    1. ↵
      Lofaso F, Dauger S, Matrot B, Vardon G, Gaultier C, Gallego J. Inhibitory effects of repeated hyperoxia on breathing in newborn mice. Eur Respir J 2007;29:18–24.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      National Health and Medical Research Council (NHMRC). National statement on ethical conduct in research involving humans. Canberra, NHMRC, 1999
    3. ↵
      Royal College of Paediatrics and Child Health: Ethics Advisory Committee. Guidelines for the ethical conduct of medical research involving children. Arch Dis Child 2002;82:177–182.
    4. ↵
      Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 1995;54:358–370.
      OpenUrlPubMedWeb of Science
    5. ↵
      Dauger S, Renolleau S, Vardon G, et al. Ventilatory responses to hypercapnia and hypoxia in Mash-1 heterozygous newborn and adult mice. Pediatr Res 1999;46:535–542.
      OpenUrlPubMedWeb of Science
    6. ↵
      Dauger S, Guimiot F, Renolleau S, et al. MASH-1/RET pathway involvement in development of brain stem control of respiratory frequency in newborn mice. Physiol Genomics 2001;7:149–157.
      OpenUrlAbstract/FREE Full Text
    7. ↵
      Carroll JL. Developmental plasticity in respiratory control. J Appl Physiol 2003;94:375–389.
      OpenUrlAbstract/FREE Full Text
    8. ↵
      Bisgard GE, Olson EBJ, Bavis RW, Wenninger J, Nordheim EV, Mitchell GS. Carotid chemoafferent plasticity in adult rats following developmental hyperoxia. Respir Physiol Neurobiol 2005;145:3–11.
      OpenUrlCrossRefPubMedWeb of Science
    9. ↵
      Dauger S, Ferkdadji L, Saumon G, et al. Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest 2003;123:530–538.
    10. ↵
      Bouferrache B, Filtchev S, Leke A, Freville M, Gallego J, Gaultier C. Comparison of the hyperoxic test and the alternate breath test in infants. Am J Respir Crit Care Med 2002;165:206–210.
      OpenUrlPubMedWeb of Science
    11. ↵
      Thomas DA, Swaminathan S, Beardsmore CS, et al. Comparison of peripheral chemoreceptor responses in monozygotic and dizygotic twin infants. Am Rev Respir Dis 1993;148:1605–1609.
      OpenUrlPubMedWeb of Science
    12. ↵
      Kinney HC, Filiano JJ, White WF. Medullary serotonergic network deficiency in the sudden infant death syndrome: review of a 15-year study of a single dataset. J Neuropathol Exp Neurol 2001;60:228–247.
      OpenUrlPubMedWeb of Science
    13. ↵
      Baillard C, Fosse JP, Sebbane M, et al. Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med 2006;174:171–177.
      OpenUrlCrossRefPubMedWeb of Science
    PreviousNext
    Back to top
    View this article with LENS
    Vol 29 Issue 1 Table of Contents
    European Respiratory Journal: 29 (1)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Requisite for stringent control of oxygen therapy in the neonatal period
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Requisite for stringent control of oxygen therapy in the neonatal period
    B. Fauroux, A. Clément
    European Respiratory Journal Jan 2007, 29 (1) 4-5; DOI: 10.1183/09031936.00132306

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Requisite for stringent control of oxygen therapy in the neonatal period
    B. Fauroux, A. Clément
    European Respiratory Journal Jan 2007, 29 (1) 4-5; DOI: 10.1183/09031936.00132306
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • THE VALUE OF ANIMAL MODELS
      • CLINICAL IMPLICATIONS
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Commemorating World Tuberculosis Day 2022
    • Is low level of vitamin D a marker of poor health or its cause?
    • Risky political game with climate change
    Show more Editorial

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society